Advisor Group Holdings, Inc. Biocept Inc Transaction History

Advisor Group Holdings, Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	SELL	$0.24 - $0.62 $240 - $620	-1,000 Reduced 50.0%	1,000 $0
Q4 2022 Feb 10, 2023	SELL	$0.47 - $0.89 $2,350 - $4,450	-5,000 Reduced 71.43%	2,000 $1,000
Q2 2022 Aug 10, 2022	SELL	$0.88 - $2.27 $2,728 - $7,037	-3,100 Reduced 30.69%	7,000 $7,000
Q1 2022 May 04, 2022	BUY	$1.83 - $3.97 $4,575 - $9,925	2,500 Added 32.89%	10,100 $23,000
Q3 2021 Nov 05, 2021	BUY	$3.39 - $4.34 $2,034 - $2,604	600 Added 8.57%	7,600 $30,000
Q4 2020 Feb 10, 2021	SELL	$4.31 - $6.16 $12,929 - $18,480	-3,000 Reduced 30.0%	7,000 $31,000
Q3 2020 Nov 12, 2020	BUY	$3.61 - $11.4 $36,100 - $114,000	10,000 New	10,000 $44,000

Ticker BIOC
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 16,922,900
Market Cap $1.18M
Description
Biocept, Inc., a molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell and circulating cell-free tumor DNA and RNA assays utilizing a standard blood sample. Its cancer assays provide information to healthcare providers to identify oncogenic alterations that qualify a subset of cancer patients for ...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.